BRF SA, Board Meeting, Jun 18, 2013. Agenda: To approve the distribution of interest on own capital to shareholders.

BRF S.A. announced that it priced international offerings of (i) 10 year bonds in the aggregate amount of USD 500 million and (ii) 5 year bonds in the aggregate amount of BRL 500 million (the 'BRL Bonds' and, together with the USD Bonds, the 'Bonds'). The USD bonds, which will mature on May 22, 2023, will be issued with a coupon of 3.95% per year (yield to maturity 4.135%), payable semi-annually beginning on November 22, 2013. The BRL bonds, which will mature on May 22, 2018, will be issued with a coupon of 7.75% per year (yield to maturity 7.75%), payable semi-annually beginning on November 22, 2013. The bonds will be senior unsecured obligations of BRF and rank pari passu with other senior unsecured indebtedness of BRF.

BR FOODS Presents at 8th Annual LatAm Ceo Conference, May-15-2013 . Venue: New York, New York, United States.

BRF - Brasil Foods S.A., Board Meeting, Apr 29, 2013. Agenda: To consider board and executive changes.

BRF - Brasil Foods S.A. reported consolidated earnings results for first quarter ended March 31, 2013. For the period, the company reported net sales were BRL 7,209 million, a year-on-year increase of 13.8% compared to BRL 6,337 million in the same period last year. EBIT was BRL 531 million compared to BRL 268 million in the same period last year. Net income rose by 134% to BRL 359 million compared to BRL 153 million in the same period last year. EBITDA was BRL 804 million compared to BRL 506 million in the same period last year. Adjusted EBITDA reached BRL 853 million compared to BRL 532 million in the same period last year. EPS was BRL 0.41 compared to BRL 0.18 in the same period last year. The company invested BRL 516 million in Capex between January and March. Net cash provided by operating activities was BRL 546 million compared to BRL 618 million in the same period last year. Acquisition of fixed assets was BRL 419 million compared to BRL 448 million in the same period last year. Acquisition of biological assets was BRL 121 million compared to BRL 117 million in the same period last year. Operating income was BRL 592 million compared to BRL 304 million in the same period last year. The company’s net debt was BRL 7.2 billion, 1.9% more than reported for December 31, 2012.